Table 1.
Baseline Patient Demographic and Clinical Characteristics
| Characteristic | Patients (N = 60) |
|
|---|---|---|
| No. | % | |
| Age, years | ||
| Median | 62 | |
| Range | 41-78 | |
| Sex | ||
| Male | 46 | |
| Female | 14 | |
| KPS, % | ||
| Median | 90 | |
| Range | 70-90 | |
| Primary site | ||
| Bladder | 49 | 82 |
| Prostate | 1 | 2 |
| Renal pelvis | 5 | 8 |
| Urethra | 2 | 3 |
| Ureter | 3 | 5 |
| Metastatic site | ||
| Visceral disease | 20 | 33 |
| Lung | 11 | 18 |
| Liver | 6 | 10 |
| Bone | 6 | 10 |
| LN only | 15 | 25 |
| Unresectable primary ± local LN | 20 | 33 |
| Unresectable primary + distant LN | 2 | 3 |
| Other* | 3 | 5 |
| Risk factor†‡ | ||
| 0 | 34 | 57 |
| 1 | 24 | 40 |
| 2 | 2 | 3 |
Abbreviations: LN, lymph node; KPS, Karnofsky performance status.
*
One patient with urethral recurrence and two patients with local recurrence.
†
Risk factors are either Karnofsky performance status < 80% or evidence of visceral metastases.17
‡
Risk factor groups are defined as follows: 0, KPS ≥ 80% and no visceral disease; 1, KPS < 80% or visceral disease; 2, KPS < 80% and visceral disease.